Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma
Year: 2025
Type: article
Language: en
Topic: interferon and immune responses
Authors and affiliations:
raw_author_name: Xin Liu
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
raw_author_name: Zelong Liu
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
raw_author_name: Chengzhan Zhu
raw_affiliation_strings: Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Tatsuya Kobayashi
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Pin-Ji Lei
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Yue Shi
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
raw_author_name: Dandan Yuan
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
raw_author_name: Jianguo Wang
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, China
raw_author_name: Min Li
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
The First Affiliated Hospital of Anhui Medical University, Hefei, China
raw_author_name: Aya Matsui
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Kanazawa University Institute of Medical, Pharmaceutical and Health Sciences Faculty of Medicine, Kanazawa, Japan
raw_author_name: Kassiana Mafra
raw_affiliation_strings: Center for Immunology and Inflammatory Diseases and Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Tomofumi Ando
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Ken Kojo
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Rieke Schleinhege
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Kento Miyazaki
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Peigen Huang
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Ming Kuang
raw_affiliation_strings: Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
raw_author_name: Lloyd Bod
raw_affiliation_strings: Broad Institute of MIT and Harvard, Cambridge, MA, USA
Center for Immunology and Inflammatory Diseases and Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Dan G. Duda
raw_affiliation_strings: Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. gduda@houstonmethodist.org
Transplant Oncology and Therapeutics Program, Department of Surgery, Houston Methodist Academic Institute, Houston, TX, USA. gduda@houstonmethodist.org
Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA